Now that Ventyx Biosciences Inc’s volume has hit 6.55 million, investors get a glimpse of its size.

Zack King

On Monday, Ventyx Biosciences Inc (NASDAQ: VTYX) was 10.84% up from the session before settling in for the closing price of $5.81. A 52-week range for VTYX has been $0.78 – $7.82.

A company in the Healthcare sector has dropped its sales by -87.13% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 15.55%. With a float of $63.19 million, this company’s outstanding shares have now reached $71.23 million.

Ventyx Biosciences Inc (VTYX) Insider Updates

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ventyx Biosciences Inc stocks. The insider ownership of Ventyx Biosciences Inc is 11.39%, while institutional ownership is 62.41%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.

Ventyx Biosciences Inc (VTYX) Performance Highlights and Predictions

According to the Wall Street analysts, stocks earnings will be around 15.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.75% during the next five years compared to -87.13% drop over the previous five years of trading.

Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators

You can see what Ventyx Biosciences Inc (VTYX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 19.12.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.68, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.90 in one year’s time.

Technical Analysis of Ventyx Biosciences Inc (VTYX)

Let’s dig in a bit further. During the last 5-days, its volume was 31.9 million. That was better than the volume of 2.06 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 65.15%.

During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 76.65%, which indicates a significant increase from 68.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.51 in the past 14 days, which was higher than the 0.26 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.17, while its 200-day Moving Average is $2.20. However, in the short run, Ventyx Biosciences Inc’s stock first resistance to watch stands at $6.89. Second resistance stands at $7.35. The third major resistance level sits at $7.90. If the price goes on to break the first support level at $5.88, it is likely to go to the next support level at $5.33. Assuming the price breaks the second support level, the third support level stands at $4.87.

Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats

There are 71,309K outstanding shares of the company, which has a market capitalization of 459.22 million. As of now, sales total 0 K while income totals -135,120 K. Its latest quarter income was 0 K while its last quarter net income were -26,990 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.